Pharmafile Logo
Pharmafocus logo
Advanced Search

European agreement to improve children’s medicines

June 2, 2006
Sales and Marketing

It will soon be easier for pharma companies to develop medicines specifically for children, after the European Parliament approved a …

News

OTC regulations to be streamlined

June 2, 2006
Sales and Marketing

The rules governing the way over-the-counter medicines are regulated are set to change as the government strives to reduce the …

News

Practice ‘clusters’ urged to lead next phase of NHS revolution

June 2, 2006

England's general practices are being urged to seize their opportunity to re-build the NHS as a primary care-led, patient-centred service, …

News

Outrage over NICE verdict on Alzheimer’s drugs

June 1, 2006
Sales and Marketing

Hundreds of thousands of patients with early or late-onset Alzheimer's disease (AD) are to be denied access to four drugs …

News

Roundhouse joins Affiniti marketing communications group

May 30, 2006
Medical Communications

Adventis, the multimedia marketing group has bought healthcare advertising agency Roundhouse for 1.6 million pounds as part of its expansion …

News

First private contractors to provide GP services

May 30, 2006

Care UK has signed a contract to provide GP services in Barking and Dagenham, making it the first private company …

News

PCT mergers bring end to uncertainty

May 30, 2006

The number of Primary Care Trusts in England is to be cut in half from 303 to just 152, the …

News

GSK investors opt for anonymity in face of animal extremist threat

May 30, 2006
Sales and Marketing

GlaxoSmithKline shareholders are using an administrative loophole to protect themselves in the face of a threatening letter campaign by animal …

News

Acomplia poised for approval as NHS focuses on fighting fat

May 30, 2006
Sales and Marketing

Acomplia, the first-of-a-kind weight-loss drug, is set to gain approval across Europe within the coming weeks, offering a new hope …

News

NICE set to recommend new ‘gold standard’ treatments for early-stage breast cancer

May 30, 2006

Three early breast cancer drugs are a step closer to overtaking the current gold standard treatment, after preliminary recommendation from …

News

Ringing the changes in pharmaceutical sales

May 25, 2006
Sales and Marketing

Every business and every market is unique, but there is a huge expanse of common ground when it comes to …

Feature

Pharmacists given new guidance on counterfeit medicines

May 24, 2006
Manufacturing and Production

Pharmacists have been asked to keep an eye out for suspected counterfeit medicines as part of a new awareness-raising initiative.Pharmacists' …

News

Pfizer’s insomnia treatment hit by ruling

May 24, 2006
Sales and Marketing

A new insomnia treatment developed by Pfizer and Neurocrine Biosciences has suffered a setback after US regulators said a high-dose …

News

Phytopharm looks for licensing partner for Alzheimer drug

May 24, 2006
Research and Development

Specialist pharma company Phytopharm says it is confident of finding a partner to develop and market one of its lead …

News

Exelon is first drug for Parkinson’s disease dementia

May 24, 2006
Research and Development

Exelon has been launched as the first ever treatment for mild to moderately severe dementia associated with idiopathic Parkinson's disease.The …

News

PCTs hiding behind NICE decision over drug, says blindness charity

May 22, 2006

A UK blindness charity says patients are being denied a new drug because PCTs are exploiting a delay in NICE's …

News

Medicom expands into branding

May 19, 2006
Business Services

PR and medical education group Medicom has launched a new consultancy that offers product and corporate branding services.The new division, …

News

Industry experts to advise Northwick Park investigation

May 19, 2006
Research and Development

Experts from the UK's pharmaceutical and biotech industries are to assist the inquiry into the Northwick Park drug trial, which …

News

AstraZeneca’s

May 18, 2006
Research and Development, Sales and Marketing

AstraZeneca is to buy Cambridge Antibody Technology for 702 million pounds in a bid to expand its reach into biotechnology.Cambridge …

News

Seroxat raises suicide risk in young adults, says GSK

May 17, 2006
Sales and Marketing

GlaxoSmithKline says new analyses of its antidepressant Seroxat show the drug raises the risk of suicidal behaviour in young adults.The …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026